Introduction Results Materials and Methods Conclusions References 1

Slides:



Advertisements
Similar presentations
Minimal Residual Disease in Hematologic Neoplasms Lloyd M. Stoolman, M.D. Professor of Pathology and Director, Clinical and Research Flow Cytometry Laboratories.
Advertisements

Supervisor: VS 高志平 Reporter: R4 張妙而.  Mutations in nucleophosmin 1 ( NPM1 ) gene, one of the most common gene mutations (25%-30%) in AML  NPM1 mut co-occurs.
How to Manage High Risk Myeloma Dr Matthew Jenner Consultant Haematologist Southampton General Hospital UK Myeloma Forum Autumn Day 12 November 2014.
Chromosome Disorders. Classification of genetic disorders  Single-gene disorders (2%)  Chromosome disorders (
ACUTE MYELOID LEUKEMIA Irit Avivi
Acute Myeloid Leukemia
Clinical Characteristics and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia With the t(4;ll) (q21;q23) By Ching-Hon Pui, Lawrence S. Frankel,
Challenges and Considerations in Linking Adult and Pediatric Leukemias David G. Poplack M.D. Texas Children’s Cancer Center Baylor College of Medicine.
The acute Leukemias are clonal hematopoietic malignant disease that arise from the malignant T r a n s f o r m a t i o n of an early Hematopoietic stem.
Heterogeneity of Abnormal RUNX1 Leading to Clinicopathological Variations in Childhood B-Lymphoblastic Leukemia Xiayuan Liang, MD Department of Pathology.
Pei Lin, MD Department of Hematopathology UT M.D. Anderson Cancer Center, Houston, TX Monitoring of Minimal Residual Disease Principles and Applications.
A Novel Approach for Unique MRD Markers Identification in Acute Leukemia Patients Tereza Jančušková synlab genetics s.r.o. Evropska 176/16, Prague, Czech.
M. Sales1, N. Foster1, S. Tauro2, J. Cunningham1, N. Pratt1
Application of Class Discovery and Class Prediction Methods to Microarray Data Kellie J. Archer, Ph.D. Assistant Professor Department of Biostatistics.
Molecular Monitoring in CML the process and questions we can answer Letizia Foroni.
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring T.R. Golub et al., Science 286, 531 (1999)
Poster Design & Printing by Genigraphics ® A Comparison of the Effects of Etomidate and Midazolam on the Duration of Vasopressor Use in.
Poster Title Weak D Types in the Egyptian Population Eiman Hussein, MD 1 and Jun Teruya, MD, DSc 2 Clinical Pathology, Division of Transfusion Medicine.
(NAAC Accredited ‘A’ grade)
INTRODUCTION & OBJECTIVES Introduction: The carcinogenesis of hepatocellular carcinoma (HCC) is a multifactorial, multistep and complex process. Its prognosis.
Therapeutic Advances in Acute Myleoid Leukemia J Clin Oncol 29: (Volume 29. Number 5. February ) Samuel Aparicio, B.M., B.Ch., Ph.D., and.
R2 김재민 / Prof. 정재헌 Journal conference 1.
CASE 411 Jose Gonzalez-Berjon, MD & Tariq Muzzafar, MD UT M.D. Anderson Cancer Center.
Preliminary Results of a Multicenter Phase II Trial of 5-Day Decitabine as Front-Line Therapy for Elderly Patients with Acute Myeloid Leukemia (AML) Cashen.
Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
Patient & tumor characteristics (n=39)
Title of the Change Project
Acute Leukemia Kristine Krafts, M.D..
Profiles of gene expression & diagnosis/prognosis of cancer
UOG Journal Club: January 2016
Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.
Shah N et al. Proc ASH 2010;Abstract 206.
Serum Vascular Endothelial Growth Factor-A Level Before and After Induction Therapy in Egyptian Children with Acute Lymphoblastic Leukemia Sayed.A. Fadel1.
Comparison of WGA methods for genotyping fetal nucleated red blood cells for the application of non-invasive prenatal diagnosis Zhouwei Huang­­1, Angela.
Raafat R. Abdel-Malek, MD, FRCR Ass. Prof Clinical Oncology
Monitoring of minimal residual disease in acute myeloid leukemia
Advances in the Management of Pediatric Acute Leukemia
CLINICAL PROGRESSION INTRODUCTION METHOD CONCLUSION REFERENCES
Table 1. The French-American-British (FAB) classification of AML
Improved diagnosis, therapy and outcomes for patients with CUP
at First Pavlov State Medical University of Saint-Petersburg, Russia
FLT3 Internal Tandem Duplication(ITD) mutation in Acute Myeloid Leukemia and its clincopathological correlation – Study from a tertiary care centre in.
Minimal Residual Disease (MRD) Detection Technologies
Cytogenetics available
Assistant Prof. Dr. Nibras Saleam Al-Ammar PhD in Clinical Immunology
Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells by Jordy Leung, Annie Pang, Wai-Hung Yuen, Yok-Lam.
STUDY ON FEATURES OF CLINIC, BIOCLINIC AND DIAGNOSIS THE SUBTYPE OF ACUTE LEUKEMIA IN VIETTIEP FRIENDSHIP HOSPITAL, Dr: Pham Thi Loc Hematology.
by Ambra Paolini, and Goretta Bonacorsi
The role of Minimal Residual Disease in
Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
Acute Myeloid Leukemia
The PML Gene Breakpoint in Acute Promyelocytic Leukemia and
Case:2 leukemia دينا نعمان جرادة جيهان ايمن مقاط.
Anthracycline Dose Intensification in Acute Myeloid Leukemia
Leukemia.
by David Grimwade, and Sylvie D. Freeman
Lymphoid Preponderance and the Absence of Basophilia
Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C
Introduction To Medical Technology
بسم الله الرحمن الرحيم Acute lymphoid leukemia(ALL) Prepared by ::
Hematology Journal Club
Jianbo Song, Danielle Mercer, Xiaofeng Hu, Henry Liu, Marilyn M. Li 
Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma Tissues 
Management Of Lassa Fever in a Resource Limited Setting: Experience From Irrua Specialist Teaching Hospital Main author: Gloria Esoimeme Co-authors:
Fluorescence In Situ Hybridization Identifies Cryptic t(16;16)(p13;q22) Masked By del(16)(q22) in a Case of AML-M4 Eo  Shakil H. Merchant, Skip Haines,
Sanger sequencing results
Chronic Myeloid Leukemia: MD-2025 Chisinau, Republic of Moldova
Reverse transcription (RT) in situ polymerase chain reaction (PCR) experiment using a single stranded biotinylated oligonucleotide probe for the detection.
Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

Introduction Results Materials and Methods Conclusions References 1 The classification and common genetic abnormalities in children with newly diagnosed acute leukemia at Hue Central Hospital, Vietnam. Authors: HA Chau Van1,THANG Nguyen Duy1,HOA PhanThi Thuy1,      HUNG Pham Hoang1,KHOA Pham Thi Minh1, WATANABE Kazuyo2. 1Hue CentralHospital, Hue, Vietnam, 2Asian Children’s Care League(ACCL), Tokyo, Japan. Introduction Results Of 50 patients analyzed, there were 38 children with ALL and 12 children with AML, median age was 3.7 year (range 2 months  to 15 years). - Regarding ALL : L1 was  common with 60.5%, L2 was less with 39.5% and L3 was rare. B cell ALL was common with 84.2%, T cell ALL was 15.8%. The frequencies of the genetic abnormalities were as follow: 9(23.7%) with t(12;21)/TEL-AML1, 2(5.3%) with t(9;22)/BCR-ABL, 3(7.9%) with t(4;11)/MLL-AF4, 4(10.5%) with t(1,19) / E2A-PBX1. - Regarding AML : M2 was  common  with 41.6%. M1 was 25.0%, M4 was 16.7%.  M6 was 16.7%., The frequencies were :1(8.3%) with t(8;21) /AML1-ETO, 2(16.6%) with t(15;17)/PML-RARA, 1(8.3%) with t(16,16)/CBFB-MYH11, 2(16.6%) with t(9;11)/MLL-AF9. 31.6% of ALL and 41.7% of AML had been chromosomal abnormalities. Hyperdiploidy were 21.1% of ALL and 25.0% of AML. Traditionally acute leukemia (AL) was classified on the basis of morphology and cytochemistry. Accurate subclassification of leukemia is essential to guide therapy and to improve patients’ outcome. The aim of this study was to implement immunophenotyping and  detect the common genetic abnormalities to classify different subtypes of acute leukemia at Hue Central Hospital. Materials and Methods This is a single institutional prospective study of 50 children newly diagnosed with AL from May 2012 to  May 2014 at Hue Central Hospital. The diagnosis was confirmed by morphological FAB criteria, cytochemistry, immunophenotype. The molecular genetic screening test using Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) was performed to detect  fusion gene transcripts.  Conclusions Diagnosis and classification of acute leukemia in Hue Central Hospital have improved by implementing immunophenotyping and detecting genetic abnormalities which can determine the subtypes of acute leukemia and to decrease errors of morphologic classification. The frequencies of the genetic abnormalities of our patients are higher than in the reported literatures. Our sample size is small; therefore, further study with larger sample size will be necessary to have the true frequencies. 1 References Silvana A, (2012). Value of Multifaced App. roach Diagnosis and Classification of Acute Leukemias, A Journal of Clinical Medicine, Vol 7 (3), pp. 254-260.D Pui C-H, (2008).Acute lymphoblastic leukemia, Lancet, 371, pp. 1030-1043.C Bain B, (2001). Morphological, Immunophenotypic, Cytogenetic, Molecular genetic (MIC-M) classification of acute leukemia, Experimental Oncology, 23, pp. 11-16.E. Ariffin H, (2003).Validation of a multiplex RT-PCR assay for screening significant oncology fusion transcripts in children with acute lymphoplastic leukemia, Singapore Med, 44, pp 517-20.